| Syndrome |
OMIM |
Gene |
GEFS+ „Generalised epilepsy with febrile seizures plus“ |
604233 |
SCN1A * |
sodium
channel, neuronal type I, alpha subunit
|
| 600235 |
SCN1B * |
beta-subunit
|
| 182390 |
SCN2A * |
alpha2-subunit |
| 137164 |
GABRG2 * |
gamma aminobutyric acid receptor, gamma-2
|
| Dravet-Syndrom, „Severe myoclonic epilepsy of infancy“, SMEI |
607208 |
SCN1A * |
sodium
channel, neuronal type I, alpha1 subunit |
| Benign familial neonatal convulsions, BFNC / BFIC |
607745 |
SCN2A * |
sodium
channel, neuronal type II, alpha2 subunit |
| Benign familial neonatal convulsions, BFNC |
607745 |
KCNQ2 * |
potassium channel, voltage-gated, KQT-like subfamily, member 2 |
| 602232 |
KCNQ3 * |
potassium channel, voltage-gated, KQT-like subfamily, member 3
|
| Verschiedene IGE-Syndrome |
600131 |
CLCN2 |
Chlorid channel 2; CAE, JAE, JME, EGMA
|
| GLUT1-Defizienz |
138140 |
SLC2A1* |
Glucose transporter GLUT1 |
| Childhood absence epilepsi, CAE |
600131 607681 |
CACNA1H * |
calcium channel, voltage-dependent, t type, alpha-1h
subunit |
| 137164 |
GABRG2 * |
gamma-aminobutyric acid
receptor |
| 138140 |
SLC2A1* |
Glukosetransporter GLUT1 |
| Generalized Epilepsy and Paroxysmal Dyskinesia |
609446 |
KCNMA1 |
large conductance calcium-sensitive potassium channel |
Juvenile myoclonic epilepsy, JME |
254770 |
EFHC1 |
EF-hand
domain-containing protein 1
|
| 606904 |
GABRA1 |
gamma-aminobutyric acid
receptor, alpha-1 |
| 601949 |
CACNB4 |
calcium channel,
voltage-dependent, beta-4 subunit |
| 137163 |
GABRD * |
gamma-aminobutyric acid
receptor, delta |
| 601949 |
CACNB4 |
calcium channel,
voltage-dependent, beta-4 subunit |
| Autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE |
605375 |
CHRNA4 |
acetylcholine receptor, neuronal nicotinic, alpha-4 subunit
|
| 600513 |
CHRNB2 |
acetylcholine receptor,
neuronal nicotinic, beta-2 subunit |
| Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE |
600512 |
LGI1 |
leucine-rich gene,
glioma-inactivated |
| Unverricht-Lundborg-Disease, ULD |
254800 |
CYSTB * |
Cystatin-B, Protease-Inhibitor
|
| Lafora-Disease |
254780 |
EPM2A |
Laforin und NHLRC1, Malin |
| Mitochondriopathien mit Epilepsie als Leitsymptom |
545000
|
MTTK *
|
transfer rna,
mitochondrial, lysine |
| 174763 |
POLG1 * |
Polymerase, DNA, gamma |
Neuronal ceroid lipofuscinosis, variant subunit
|
125370 |
CLN1 - CLN8 |
|
| Sialidosen |
608272 |
NEU1 |
alpha-neuraminidase |
| |
256540 |
PPCA |
beta-Galaktosidase protective protein |
| X-linked West-Syndrom, ISSX, infantile spasm syndrome |
308350 |
ARX * |
X-chromosomal
|
| Infantile Epilepsie |
300203 |
CDKL5 * |
Cyclin-dependent kinase-like 5 |
| Periventrikuläre Heterotopie, X-chromosomal |
300049 |
FLNA |
Filamin-A |
| Lissenzephalie, X-chromosomal |
300067 |
DCX |
Doublecortin |
| Lissenzephalie, LIS1 |
607432 |
LIS1, PAFAH1B1 |
Platelet-Activating Factor Acetylhydrolase
|
| Miller-Dieker-Lissenzephalie |
247200 |
Microdeletion17p13.3 inclusive LIS1-Gen * |
| Lissenzephalie mit abnormalen Genitalien, XLAG |
300215 |
ARX * |
Aristaless-related homeobox, X-linked |
| XMESID-Syndrom, X-linked myoclonic epilepsy with generalized spasticity and intellectual disability |
300432 |
ARX * |
Aristaless-related homeobox, X-linked |
| Ohtahara-Syndrom |
602926 |
STXBP1* |
Syntaxin-binding protein 1 |
| Fragiles X-Syndrom |
309550 |
FMR1 * |
fragile X mental retardation |
| X-linked,
epilepsy, with variable learning disabilities and behavior disorders |
300491 |
SYN1 |
Synapsin 1 |
| Angelman-Syndrom |
105830 |
Maternal 15q11q13-Deletion * |
| 601623 |
UBE3A |
Ubiquitin protein-ligase, 15q11q13 |
| 300231 |
SCL9A6* |
Solute carrier family 9, member 6 |
X-chromosomale Epilepsie, Ataxie, DD Angelman-Syndrom |
300231 |
SLC9A6 * |
Solute carrier family 9, member 6 |
| Rett-Syndrom |
312750 |
MECP2 * |
Methyl-CpG-binding protein 2 |
| |
300203 |
CDKL5* |
Cyclin-dependent kinase-like 5 |
| 164874 |
FOXG1* |
Forkhead box G1 |